CSI Market
Sign In | Register

Q32 Bio Inc (QTTB) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access QTTB quarterly Cash Flow →
A period-by-period view of cash flow from Q32 Bio Inc to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income29.82
Depreciation & amortization0.39
Amortization of Other Assets0.18
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Sale of Assets and Asset Impairment Charges-11.74
Share-based Compensation5.26
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Right Of Use Asset Amortization-
Non Cash Lease Expense-
Accretion Of Short Term Investments-
Operating Lease Right Of Use Asset Amortization Expense0.62
Change In Fair Value Of Convertible Notes-
Increase Decrease In Operating Lease Liability-53.74
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-2.11
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-3.33
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.90
Other Working Capital0.12
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.91
Discontinued operations0.00
Net Cash flow from Operating Activities-33.54
Investing Activities
Capital Expenditures0.00
Sale of Capital Items7.00
Proceeds from Sale of Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sale Of Business-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities7.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-4.09
Reclassification Of Liability For Common Stock Vested In Noncash Transactions-
Capital Expenditures Incurred But Not Yet Paid0.96
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level-
Proceeds From Issuance Of Restricted Common Stock-
Repurchase Of Unvested Common Stock-
Proceeds From Issuance Of Common Stock Pursuant To Atm Financing Net Of Discounts And Issuance Costs-
Proceeds From Reverse Recapitalization-
Payment Of Reverse Recapitalization Transaction Costs-
Payment On Venture Debt-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-3.13
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-26.54
Total Cash Flow-29.67
4 historic quarters locked

Sign in to unlock the full Q32 Bio Inc cash flow history.

Sign In Create Free Account

About Q32 Bio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-099339

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License